FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Viatris Cardura XL Recall

Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distrib…

Viatris Inc · Canonsburg, PA

Risk level
Class II
Reported by FDA
Jan 22, 2025
Recall ID
D-0203-2025
Check your lot numberHow we source this data

Summary

Viatris recalled Cardura XL starting Dec 23, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0203-2025 on Jan 22, 2025. Reason: Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

Product description

Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93

Lot numbers, UPCs & expiration codes

Lot # 8181625, Exp 12/31/2025

Where it was sold

USA nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0203-2025
Classification
Class II
Status
Terminated
Recall initiated
Dec 23, 2024
FDA report date
Jan 22, 2025
Quantity
1,215/30 count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Viatris Inc

Original FDA data

Every field from FDA enforcement report D-0203-2025, exactly as published.

Show all FDA fields
City
Canonsburg
State
PA
Status
Terminated
Country
United States
Event ID
96036
Address
1000 Mylan Blvd
Code information
Lot # 8181625, Exp 12/31/2025
Postal code
15317-5853
Report date
Jan 22, 2025
Product type
Drugs
Recall number
D-0203-2025
Classification
Class II
Recalling firm
Viatris Inc
Product quantity
1,215/30 count bottles
Termination date
Nov 12, 2025
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93
Distribution pattern
USA nationwide.
Recall initiation date
Dec 23, 2024
Initial firm notification
Letter
Center classification date
Jan 16, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0203-2025, published Jan 22, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls